These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12071577)

  • 21. Effective molecular RHD typing strategy for blood donations.
    Polin H; Danzer M; Hofer K; Gassner W; Gabriel C
    Transfusion; 2007 Aug; 47(8):1350-5. PubMed ID: 17655577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G; Finning K; Martin P; Summers J
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
    Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
    Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal blood group genotyping: present and future.
    Daniels G; Finning K; Martin P; Summers J
    Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rh proteins: key structural and functional components of the red cell membrane.
    Van Kim CL; Colin Y; Cartron JP
    Blood Rev; 2006 Mar; 20(2):93-110. PubMed ID: 15961204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rh system genotyping in amniotic fluid].
    Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Martino W; Racca A
    Medicina (B Aires); 2001; 61(1):76-8. PubMed ID: 11265629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhd and C/cE/e genotyping in Slovenian population.
    Rupreht RR; Faas BH; Bojanic V; van Wijk PA; Glonar L; Bricl I; Rozman P; Curin Serbec V
    Pflugers Arch; 2000; 439(3 Suppl):R58-9. PubMed ID: 10653143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunohematologic surveillance of the pregnant woman and the new prevention policy of anti-RH1 allo-immunization].
    Mannessier L
    Transfus Clin Biol; 2007 May; 14(1):112-9. PubMed ID: 17524695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors.
    Luettringhaus TA; Cho D; Ryang DW; Flegel WA
    Transfusion; 2006 Dec; 46(12):2128-37. PubMed ID: 17176325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular approaches to the Rh blood group system].
    Kajii E
    Nihon Hoigaku Zasshi; 2006 Oct; 60(2):110-9. PubMed ID: 17134012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-D immunization by DEL red blood cells.
    Wagner T; Körmöczi GF; Buchta C; Vadon M; Lanzer G; Mayr WR; Legler TJ
    Transfusion; 2005 Apr; 45(4):520-6. PubMed ID: 15819672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular aspects of Rh antigens.
    Iwamoto S
    Leg Med (Tokyo); 2005 Jul; 7(4):270-3. PubMed ID: 15946885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma.
    Brojer E; Zupanska B; Guz K; Orziñska A; Kaliñska A
    Transfusion; 2005 Sep; 45(9):1473-80. PubMed ID: 16131380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.
    Minon JM; Gerard C; Senterre JM; Schaaps JP; Foidart JM
    Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The RHD gene is highly detectable in RhD-negative Japanese donors.
    Okuda H; Kawano M; Iwamoto S; Tanaka M; Seno T; Okubo Y; Kajii E
    J Clin Invest; 1997 Jul; 100(2):373-9. PubMed ID: 9218514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular biology of partial D and weak D: implications for blood bank practice.
    Flegel WA; Wagner FF
    Clin Lab; 2002; 48(1-2):53-9. PubMed ID: 11833677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma.
    Finning K; Martin P; Summers J; Daniels G
    Transfusion; 2007 Nov; 47(11):2126-33. PubMed ID: 17958542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new DEL variant caused by exon 8 deletion.
    Richard M; Perreault J; Constanzo-Yanez J; Khalifé S; St-Louis M
    Transfusion; 2007 May; 47(5):852-7. PubMed ID: 17465950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.